TherapeuticsMD (TXMD) EV to EBIT (2022 - 2023)
TherapeuticsMD's (TXMD) EV to EBIT stood at 0.52 in Q3 2023, down 49.4% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) EV to EBIT (2022 - 2023) Analysis & Trends
On a TTM basis, TherapeuticsMD's EV to EBIT came in at -1.41 as of Sep 30, 2023; for FY2022, it was 3.17.
- Per Business Quant, the preceding three quarters came in at 1.04 (Q2 2023), 1.13 (Q1 2023) and 3.17 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | TherapeuticsMD | 20.14 Mn | -12.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 0.52 |
| Jun 30, 2023 | 1.04 |
| Mar 31, 2023 | 1.13 |
| Dec 31, 2022 | 2.06 |
API Access
TherapeuticsMD EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();